SCHEMBL4192953

SCHEMBL4192953

C[C@@H](CC1CCCCC1)NCc1ccccc1NS(=O)(=O)c1ccc2sc(N)nc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.47
ATM Q13315 1/20 0.47
PKM P14618 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 6/20 0.41
LMNA P02545 6/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
USP2 O75604 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TP53 P04637 4/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
THRB P10828 2/20 0.33
VDR P11473 1/20 0.33
HPGD P15428 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186018 0.93 ALDH1A1 (0.43) MAPTATMPKMKDM4EALDH1A1
SCHEMBL4197657 0.92 ALDH1A1 (0.44) MAPTATMPKMKDM4EALDH1A1
SCHEMBL4194631 0.89 ALDH1A1 (0.46) MAPTATMPKMKDM4EALDH1A1
SCHEMBL4190737 0.83 ALDH1A1 (0.43) MAPTPKMKDM4EALDH1A1LMNA
SCHEMBL4194032 0.83 PKM (0.42) MAPTPKMKDM4EALDH1A1LMNA
SCHEMBL4191257 0.83 PKM (0.45) MAPTPKMKDM4EALDH1A1LMNA
SCHEMBL4200050 0.83 ALDH1A1 (0.41) MAPTATMPKMKDM4EALDH1A1
SCHEMBL4192397 0.83 TSHR (0.50) MAPTPKMKDM4EALDH1A1LMNA
SCHEMBL4194915 0.82 ALDH1A1 (0.44) MAPTPKMKDM4EALDH1A1LMNA
SCHEMBL4189896 0.82 MEN1 (0.38) MAPTPKMKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 MAPT 2269/4885ATM 1301/4885PKM 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.